Beta-cell death and dysfunction drives hyperglycaemia in organ donors

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Donor hyperglycaemia following brain death has been attributed to reversible insulin resistance. However, our islet and pancreas transplant data suggest that other mechanisms may be predominant. We aimed to determine the relationships between donor insulin use and markers of beta-cell death and beta-cell function in pancreas donors after brain death. Methods: In pancreas donors after brain death, we compared clinical and biochemical data in ‘insulin-treated’ and ‘not insulin-treated donors’ (IT vs. not-IT). We measured plasma glucose, C-peptide and levels of circulating unmethylated insulin gene promoter cell-free DNA (INS-cfDNA) and microRNA-375 (miR-375), as measures of beta-cell death. Relationships between markers of beta-cell death and islet isolation outcomes and post-transplant function were also evaluated. Results: Of 92 pancreas donors, 40 (43%) required insulin. Glycaemic control and beta-cell function were significantly poorer in IT donors versus not-IT donors [median (IQR) peak glucose: 8 (7-11) vs. 6 (6-8) mmol/L, p =.016; C-peptide: 3280 (3159-3386) vs. 3195 (2868-3386) pmol/L, p =.046]. IT donors had significantly higher levels of INS-cfDNA [35 (18-52) vs. 30 (8-51) copies/ml, p =.035] and miR-375 [1.050 (0.19-1.95) vs. 0.73 (0.32-1.10) copies/nl, p =.05]. Circulating donor miR-375 was highly predictive of recipient islet graft failure at 3 months [adjusted receiver operator curve (SE) = 0.813 (0.149)]. Conclusions: In pancreas donors, hyperglycaemia requiring IT is strongly associated with beta-cell death. This provides an explanation for the relationship of donor IT with post-transplant beta-cell dysfunction in transplant recipients.

References Powered by Scopus

Stress hyperglycaemia

1047Citations
N/AReaders
Get full text

Identification of tissue-specific cell death using methylation patterns of circulating DNA

468Citations
N/AReaders
Get full text

Repeating experiments is not enough

422Citations
N/AReaders
Get full text

Cited by Powered by Scopus

F2RL1 Inhibition Alleviates Lipotoxicity-Induced Kidney Injury Through the Hippo Pathway in Diabetic Kidney Disease

0Citations
N/AReaders
Get full text

Absent in Melanoma (AIM)2 Promotes the Outcome of Islet Transplantation by Repressing Ischemia-Induced Interferon (IFN) Signaling

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shapey, I. M., Summers, A., O’Sullivan, J., Fullwood, C., Hanley, N. A., Casey, J., … van Dellen, D. (2023). Beta-cell death and dysfunction drives hyperglycaemia in organ donors. Diabetes, Obesity and Metabolism, 25(12), 3529–3537. https://doi.org/10.1111/dom.15248

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

100%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

100%

Save time finding and organizing research with Mendeley

Sign up for free